People: Consun Pharmaceutical Group Ltd (1681.HK)
24 Jun 2019
Mr. An Yubao is Executive Chairman of the Board of Consun Pharmaceutical Group Limited. a Controlling Shareholder. He was appointed as our Director with effect from 24 January 2011. He is also the chairman of Guangzhou Consun Pharmaceutical Company Limited (“GZ Consun”), Consun Pharmaceutical (Inner Mongolia) Company Limited (“Consun (Inner Mongolia)”) and Inner Mongolia Kangyuan Pharmaceutical Company Limited (“Kangyuan”) and a director and the legal representative of Guangzhou Consun Pharmaceutical Research Company Limited (“Consun Research”). Mr. An is primarily responsible for the overall management, operations, investment and the charting and reviewing of corporate directions and strategies of our Group. Mr. An has over 10 years of experience in medical education and approximately 19 years of experience in the business of the pharmaceutical industry. He has served various key positions, such as executive director, chairman and legal representative of GZ Consun since its establishment. Mr. An served as the vice chairman of (Guangdong Southern Lee Kum Kee Commercial Information Centre) from November 1995 to February 1999. From July 1996 to December 1998, Mr. An started his career in the pharmaceutical industry by serving as the chairman and legal representative of (Guangdong Southern Lee Kum Kee Nutrition Health Products Co., Ltd.) and representing (the First Military Medical University of the People’s Liberation Army of the PRC) as one of its shareholders. Mr. An served as the minister and vice president respectively of (Southern Medical University) (formerly known as the First Military Medical University of the People’s Liberation Army of the PRC)) from November 1991 to August 2001 and served as the vice president of (Jinan Military General Hospital) from 1987 to 1988. Between 1981 and 1987.
|Total Annual Compensation, CNY||4,653,000|
|Restricted Stock Award, CNY||--|
|Long-Term Incentive Plans, CNY||--|
|All Other, CNY||9,748,000|
|Fiscal Year Total, CNY||14,401,000|